Insider · CIK 0001759822
Randall Michael Giuffre
Files at DMAC (DiaMedica Therapeutics Inc.). First filing -, latest -.
Randall Michael Giuffre files SEC Form 4 as director at DMAC (DiaMedica Therapeutics Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Randall Michael Giuffre has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | DMAC DiaMedica Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +40,412 | $0.00 | $0 | 40,412 | Jun 3, 2026 |
| Jan 2, 2026 | DMAC DiaMedica Therapeutics Inc. | AGrant or award Common Stock | +6,175 | $8.42 | $52k | 398,587 | Jan 6, 2026 |
| Jun 1, 2025 | DMAC DiaMedica Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +32,162 | $0.00 | $0 | 32,162 | Jun 3, 2025 |
| Feb 13, 2025 | DMAC DiaMedica Therapeutics Inc. | MOption exercise Voting Common Shares, no par value per share | +12,000 | $2.11 | $25k | 387,412 | Feb 18, 2025 |
| Feb 13, 2025 | DMAC DiaMedica Therapeutics Inc. | MOption exercise Voting Common Shares, no par value per share | +5,000 | $3.65 | $18k | 392,412 | Feb 18, 2025 |
| Feb 13, 2025 | DMAC DiaMedica Therapeutics Inc. | MOption exercise Stock Option (right to buy)derivative | -12,000 | $0.00 | $0 | 0 | Feb 18, 2025 |
| Feb 13, 2025 | DMAC DiaMedica Therapeutics Inc. | MOption exercise Stock Option (right to buy)derivative | -5,000 | $0.00 | $0 | 0 | Feb 18, 2025 |
| Jan 2, 2025 | DMAC DiaMedica Therapeutics Inc. | AGrant or award Voting Common Shares, no par value per share | +10,861 | $5.34 | $58k | 375,412 | Jan 3, 2025 |
Questions about Randall Michael Giuffre
Answered from the filings on this page, as of the latest one.
Is Randall Michael Giuffre buying or selling?
Randall Michael Giuffre has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Randall Michael Giuffre's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Randall Michael Giuffre has 0.
Where does Randall Michael Giuffre file Form 4?
Randall Michael Giuffre has filed Form 4 at DMAC (DiaMedica Therapeutics Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.